Author:
Waud William R.,Gilbert Karen S.,Shepherd Rodney V.,Montgomery John A.,Secrist John A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference11 articles.
1. Anonymous (2000) Drugs of choice for cancer chemotherapy. Med Lett 42:83
2. Braakhuis BJM, Ruiz van Haperen VWT, Boven E, Veerman G, Peters GJ (1995) Schedule-dependent antitumor effect of gemcitabine in in vivo model systems. Semin Oncol 22:42
3. FDA (2003) List of approved oncology drugs with approved indications. http://www.fda.gov/cder/cancer/druglistframe.htm
4. Gish DT, Kelly RC, Camiener GW, Wechter WJ (1971) Nucleic acids. 11. Synthesis of 5′-esters of 1-β-d-arabinofuranosylcytosine possessing antileukemic and immunosuppressive activity. J Med Chem 14:1159
5. Hertel LW, Kroin JS, Grossman CS, Grindey GB, Dorr AF, Storniolo AMV, Plunkett W, Gandhi V, Huang P (1996) Synthesis and biological activity of 2′,2′-difluorodeoxycytidine (gemcitabine). In: Ojima I, McCarthy JR, Welch JT (eds) Biomedical frontiers of fluorine chemistry. American Chemical Society, Washington, DC, p 265
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献